ArticleInvestigational new drugs2022

A novel SLC8A1/LINC01913 intergenic region-ALK fusion identified by NGS and validated by IHC and FISH in a stage IIB lung adenocarcinoma patient who remains relapse-free during the treatment of crizotinib: a case report.

Chunguang Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.